Skip to main content
. 2018 Aug 14;2018(8):CD012791. doi: 10.1002/14651858.CD012791.pub2

ACTRN12617000347369 2017.

Trial name or title HOMeCare: caring for the dementia caregiver and their loved one via the HOMeCare exercise and mindfulness for health program
Methods Randomised controlled trial
Participants Unit: a dyad composing of 1 carer (family or friend) and 1 individual with mild‐to‐moderate dementia
Inclusion criteria for carers:
  • 18 years or older

  • Able to use iPad programs


Inclusion criteria for the participant with dementia:
  • Living in the community

  • Mini‐Mental State Exam score 12 to 24/30

  • Mild deficits in functional mobility (Short Physical Performance Battery score < 10/12)

  • Ambulatory over short distances without the assistance of others


Exclusion criteria:
  • Disease or illness resulting in carers or individuals with dementia not being able to perform interventions

  • Having a severe dementia (Mini‐Mental Exam score < 12) for the participant with dementia

  • Having moderate‐to‐severe deficits in functional mobility (Short Physical Performance Battery score of > 10/12) for the participant with dementia

Interventions Intervention: an online 8‐week mindfulness‐based stress reduction training for the carer followed by a 16‐week home‐based exercise programme for the individual with dementia
Control: usual care
Outcomes Primary outcomes: funtional mobility for the adult with dementia and state mindfulness for the carer at baseline, 8 weeks, and 6 months
Secondary outcomes: quality of life of the individual with dementia, carer depression, quality of life of carers, cognition of the person with dementia, physical capacity of the adult with dementia, etc.
Starting date Date of first participant enrolment: 12 June 2017
Contact information Mr Kenneth Daniel, University of Sydney, kenneth.daniel@sydney.edu.au
Notes Contact person reply (13 December 2017): "The HOMeCARE study is currently ongoing as we are still recruiting more potential participants for the study. Publication of the paper would most likely occur sometime in the next year (2018)."